BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

14 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases.EBI
Intra-Cellular Therapies
Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders.EBI
Intra-Cellular Therapies
Discovery of novel alpha7 nicotinic receptor antagonists.EBI
Intra-Cellular Therapies
RNA virus inhibitor compounds and uses thereofBDB
University of Alberta
NOVEL COMPOUNDSBDB
Sitryx Therapeutics
Indazole carboxamides as kinase inhibitorsBDB
Bristol-Myers Squibb
SELECTIVE MODULATORS OF ATAXIA TELANGIECTASIA MUTATED (ATM) KINASE AND USES THEREOFBDB
Suzhou Zanrong Pharma
Kinase inhibitors and their use in cancer therapyBDB
Technische UniversitÄT Dortmund
Benzimidazole derivates useful as inhibitors of mammalian histone deacetylase activityBDB
Kancera
Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain.BDB
Oncology Innovative Medicines Unit
Heteroaryl substituted nicotinamide compoundsBDB
Bristol-Myers Squibb
1,4-benzodiazepine-2,5-diones and related compounds with therapeutic propertiesBDB
University of Michigan
2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists.BDB
Universita Degli Studi Di Milano